Critical Updates: Field Safety Notices Issued from 8–12 September 2025
Important updates for clinical, quality, and regulatory teams: A series of Field Safety Notices (FSNs) were published between 8 and […]
Important updates for clinical, quality, and regulatory teams: A series of Field Safety Notices (FSNs) were published between 8 and […]
The U.S. Food and Drug Administration (FDA) announced on September 29, 2025, the authorization of Essilor Stellest eyeglass lenses. This
Olympus Corporation has announced a voluntary global recall of certain lots of its ViziShot 2 FLEX (19G) EBUS-TBNA needles. The
The U.S. Food and Drug Administration (FDA) has authorized the marketing of Essilor Stellest eyeglass lenses. This marks the first
Swissmedic has officially authorised VANFLYTA®, marking its initial regulatory approval. This announcement, dated September 30, 2025, highlights a significant development
Healthcare professionals and regulatory teams, please take note. Between 15 and 19 September 2025, a range of Field Safety Notices
On June 24, 2025, the Global Harmonization Working Party (GHWP) officially withdrew as a member of the International Medical Device
Clinical testing on the Thermage® FLX device is set to evaluate its safety and effectiveness in treating skin laxity and
This announcement marks a pivotal step forward for medical diagnostics and research. A new clinical study, sponsored by POROUS GmbH
On October 5, 2025, a new milestone in pain management research was shared. Florida International University and Baptist Health South